Infliximab in a child with therapy-resistant systemic vasculitis.
Treatment of systemic vasculitides is usually based on the use of corticosteroids and other immunosuppressive drugs. We describe a 10-year-old girl with systemic vasculitis resistant to immunosuppressive treatment who had a rapid and impressive response to treatment with infliximab.
de Kort
Sandra W K
SW
Amphia Hospital, Breda, The Netherlands.
van Rossum
Marion A J
MA
ten Cate
Rebecca
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002648:Child; D005260:Female; D006801:Humans; D000069285:Infliximab; D010488:Polyarteritis Nodosa / Q000188:drug therapy* / Q000473:pathology; D012074:Remission Induction; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab